James Ingle

Apr 18, 2023 | nature.com | Xue Wang |David Hillman |Heikki Joensuu |Judy Boughey |Minetta C. Liu |James Ingle | +1 more

This study was conducted in accordance with recognized ethical guidelines, including the U.S. Common Rule. The FinXX study was approved by an Institutional Review Board at the Helsinki University Hospital (approvals 264/13/03/02/2014 and HUS/903/2017). The patients who participated in the FinXX trial (NCT00114816) signed a written informed consent to the trial participation and consent to allow the use of their tumor tissue for FinXX trial-related research purposes.